Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Oversold Conditions For Kailera Therapeutics (KLRA)
posted:
Fri, 10/02/2026 - 16:34 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Fulcrum Therapeutics Consensus Price Target Raised 11.22% to $7.75
posted:
Fri, 10/02/2026 - 09:57 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
NeuroSense Therapeutics Consensus Price Target Increased by 1,507.27% to $112.71
posted:
Fri, 10/02/2026 - 07:10 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
BlossomHill Therapeutics Average Analyst Price Target Raised 10.53% to $37.48
posted:
Fri, 10/02/2026 - 06:14 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32
posted:
Fri, 10/02/2026 - 05:47 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Capricor Therapeutics Average Analyst Price Target Rises 12.70% to $24.14
posted:
Thu, 10/01/2026 - 22:47 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Spero Therapeutics Consensus Price Target Raised 25% to $5.10
posted:
Thu, 10/01/2026 - 20:06 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
HC Wainwright & Co. initiates coverage of Monte Rosa Therapeutics with a Buy rating
posted:
Thu, 10/01/2026 - 06:36 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
August 2027 Options Now Available For Halozyme Therapeutics (HALO)
posted:
Mon, 09/28/2026 - 10:56 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Sarepta Therapeutics Enters Oversold Territory (SRPT)
posted:
Tue, 05/28/2024 - 11:58 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
posted:
Fri, 05/24/2024 - 12:25 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Neumora Therapeutics Enters Oversold Territory (NMRA)
posted:
Fri, 05/24/2024 - 12:10 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Up 165% This Year Will Dyne Therapeutics Continue Its Stellar Run?
posted:
Wed, 05/22/2024 - 21:45 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Oppenheimer Initiates Coverage of Capricor Therapeutics (CAPR) with Outperform Recommendation
posted:
Sat, 05/18/2024 - 04:32 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Raymond James Upgrades Viking Therapeutics (VKTX)
posted:
Thu, 05/16/2024 - 20:01 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Pagination
Page 1
Next page
››